Catalyst Pharmaceuticals, Inc. (CPRX)

24.44 +0.53 (+2.22%) USD  |  NASDAQ  |  Feb 06, 16:00
24.45 +0.01 (+0.04%) After-Hours: 20:00
More

Catalyst Pharmaceuticals SG&A Expense (TTM) : 162.44M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for CPRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Rigel Pharmaceuticals, Inc. 115.43M
United Therapeutics Corp. 627.50M
Supernus Pharmaceuticals, Inc. 442.58M
Zoetis, Inc. 2.384B
Krystal Biotech, Inc. 136.75M